FDA Clearance Tracker · P140003-S125
Impella 2.5, Impella CP, Impella CP with SmartAssist, Impella 5.0, Impella 5.5 with SmartAssist, and Impella LD
Last checked: Nov 20, 2026Latest source record: Jun 23, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Jun 23, 2025
Approved
Time to decision
88 days
Received Mar 27, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P140003-S125
- Device name
- Impella 2.5, Impella CP, Impella CP with SmartAssist, Impella 5.0, Impella 5.5 with SmartAssist, and Impella LD
- Applicant
- Abiomed, Inc.
- Applicant location
- Danvers, MA
- Received
- Mar 27, 2025
- Decided
- Jun 23, 2025
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P140003
Device type
- Device class
- Class III
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
approval for a change to the Automated Impella Controller (AIC) battery pack cells and gas gauge integrated circuit
Source documents
Other decisions for Abiomed, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K252766 · Decided Oct 8, 2025 · 40 days after receipt
Device type: Introducer, Catheter (DYB) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.